{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:08Z","timestamp":1791849728544,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd013506","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000}}],"reference-count":122,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013506.pub2","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T05:58:13Z","timestamp":1653544693000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2022","author":[{"given":"Han","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Medicine; Newcastle University Medicine Malaysia; Johor Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swe Zin","family":"Aye","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health; Quest International University Perak; Ipoh Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho","family":"Naing","sequence":"additional","affiliation":[{"name":"Division of Tropical Health and Medicine; James Cook University; Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3126\/jiom.v43i1.37461","article-title":"Nebulized magnesium sulphate versus saline as an adjuvant in acute exacerbation of chronic obstructive pulmonary disease in a tertiary centre of Nepal: a randomised control study","volume":"43","author":"Bajracharya","year":"2021","journal-title":"Journal of Institute of Medicine Nepal"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5578\/tt.9854","article-title":"Efficiency of nebulised magnesium sulphate in infective exacerbations of chronic obstructive pulmonary disease","volume":"64","author":"Comert","year":"2016","journal-title":"Tuberkuloz ve Toraks"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD013506.pub2-BIB0003|cit3","first-page":"1275","article-title":"Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease","volume":"28","author":"Sunmez","year":"2006","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0004|cit4","unstructured":"A study to investigate the effects of nebulised magnesium in severe exacerbations of chronic obstructive pulmonary disease (COPD) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=82699"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thoraxjnl-2012-202225","article-title":"Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial","volume":"68","author":"Edwards","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0006|cit6","first-page":"343s","article-title":"A single centre double blind placebo controlled pilot study in the use of intravenous magnesium sulphate for the treatment of acute exacerbation of chronic obstructive airways disease (COPD)","volume":"24","author":"Hogg","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0007|cit7","unstructured":"The effect of intravenous magnesium sulfate as a complementary therapy to COPD en.irct.ir\/trial\/18822"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0008|cit8","first-page":"267","article-title":"The effect of intravenous magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in the emergency department: a double-blind randomised clinical trial","volume":"31","author":"Jahanian","year":"2021","journal-title":"Ethiopian Journal of Health Sciences"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0009|cit9","unstructured":"The effect of IV magnesium sulfate on dyspnoea improving of patients with chronic obstructive pulmonary disease en.irct.ir\/trial\/17716"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/acem.14050","article-title":"The adjunctive effect of intravenous magnesium sulfate in acute exacerbation of chronic obstructive pulmonary disease: a randomised controlled clinical trial","volume":"28","author":"Vafadar Moradi","year":"2021","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0011|cit11","unstructured":"Intravenous magnesium as an adjunct treatment in acute exacerbations of chronic obstructive pulmonary disease www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=364675"},{"issue":"1425","key":"10.1002\/14651858.CD013506.pub2-BIB0012|cit12","first-page":"34","article-title":"Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study","volume":"128","author":"Mukerji","year":"2015","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0013|cit13","unstructured":"Magnesium sulfate versus ipratropium bromide in acute exacerbation of chronic obstructive pulmonary disease clinicaltrials.gov\/ct2\/show\/NCT01136421"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MJT.0b013e3182459a8e","article-title":"Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomised trial","volume":"21","author":"Nouira","year":"2014","journal-title":"American Journal of Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013506.pub2-BIB0015|cit15","first-page":"P228","article-title":"Intravenous magnesium sulfate in the treatment of acute exacerbations of COPD: a randomised controlled trial","volume":"22","author":"Pishbin","year":"2018","journal-title":"Critical Care"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jemermed.2017.08.061","article-title":"Intravenous magnesium sulfate in the treatment of acute exacerbations of COPD","volume":"53","author":"Pishbin","year":"2017","journal-title":"Journal of Emergency Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archinte.1995.00430050072008","article-title":"Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease","volume":"155","author":"Skorodin","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0018|cit18","first-page":"1235","article-title":"Magnesium sulfate in exacerbations of COPD in patients admitted to internal medicine ward","volume":"13","author":"Solooki","year":"2014","journal-title":"Iranian Journal of Pharmaceutical Research"},{"issue":"8","key":"10.1002\/14651858.CD013506.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1579-2129(06)60551-X","article-title":"Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalisation: a randomised placebo-controlled trial","volume":"42","author":"Abreu Gonzalez","year":"2006","journal-title":"Archivos de Bronconeumologia"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0020|cit20","unstructured":"Effects of inhaled magnesium on pulmonary function and walking distance of patients with stable chronic obstructive pulmonary disease (COPD) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=83127"},{"issue":"10","key":"10.1002\/14651858.CD013506.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/aas.13684","article-title":"Intraoperative MgSO4 infusion protects oxygenation and lung mechanics in COPD patients during general anaesthesia. A randomised clinical trial","volume":"64","author":"Ahmed","year":"2020","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD013506.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.6061\/clinics\/2012(06)12","article-title":"The effect of acute magnesium loading on the maximal exercise performance of stable chronic obstructive pulmonary disease patients","volume":"67","author":"Amaral","year":"2012","journal-title":"Clinics"},{"issue":"10","key":"10.1002\/14651858.CD013506.pub2-BIB0023|cit23","first-page":"CR524","article-title":"Effects of acute magnesium loading on pulmonary function of stable COPD patients","volume":"14","author":"Amaral","year":"2008","journal-title":"Medical Science Monitor"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0024|cit24","first-page":"A1543","article-title":"Effects of acute magnesium loading on maximal exercise performance of stable COPD patients","volume":"185","author":"Baddini","year":"2012","journal-title":"ATS Journals"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0025|cit25","unstructured":"Martinez JA Amaral AF Teixeira CA Gallo L Terra Filho J Kazuki RT The effects of intravenous magnesium loading on pulmonary function of COPD patients in stable clinical conditions American Thoracic Society International Conference; 2007 May 18-23; San Francisco 2007"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0026|cit26","unstructured":"Magnesium loading in chronic obstructive pulmonary disease clinicaltrials.gov\/ct2\/show\/NCT00500864"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0027|cit27","unstructured":"A study to compare and know the beneficial role of intravenous magnesium sulfate vs placebo as an add on therapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2018\/01\/011354"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0028|cit28","unstructured":"A study to compare the costs between intravenous Magnesium Sulfate and placebo in acute exacerbations of chronic obstructive pulmonary disease www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2018\/04\/013309"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0029|cit29","first-page":"959","article-title":"Effect of magnesium sulfate and oxygen inhalation on pulmonary function in elderly chronic obstructive pulmonary disease during acute attack","volume":"15","author":"Fan","year":"2015","journal-title":"Journal of Tropical Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0030|cit30","first-page":"311","article-title":"Effect of a magnesium therapy on chronic obstructive lung diseases","volume":"42","author":"Friemann","year":"1991","journal-title":"Die Medizinische Welt"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0031|cit31","unstructured":"The use of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease (COPD) - nebulised magnesium in COPD www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2006-002484-99-GB"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0032|cit32","unstructured":"The use of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN65174202"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0033|cit33","first-page":"203","article-title":"Best evidence topic report. Intravenous magnesium in chronic obstructive pulmonary disease","volume":"21","author":"Jenner","year":"2004","journal-title":"Emergency Medicine Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0034|cit34","unstructured":"Marino P Belloli E Invernizzi F Magnesium sulfate in chronic obstructive pulmonary disease European Respiratory Society 9th Annual Congress; 1999 Oct 9-13; Madrid 1999"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0035|cit35","unstructured":"Daily magnesium-treatment of patients with chronic obstructive pulmonary disease clinicaltrials.gov\/ct2\/show\/NCT01118936"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0036|cit36","unstructured":"Magnesium sulfate to prevent hospitalisation of acute exacerbations of chronic obstructive pulmonary disease clinicaltrials.gov\/ct2\/show\/NCT02498496"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0037|cit37","unstructured":"Effect of magnesium supplementation in COPD clinicaltrials.gov\/ct2\/show\/NCT02680769"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0038|cit38","first-page":"38","article-title":"Magnesium in obstructive respiratory tract disease","volume":"8","author":"Schenk","year":"2001","journal-title":"Journal fur Mineralstoffwechsel"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archinte.1995.00430050072008","article-title":"Magnesium sulfate and ipratropium bromide combination in the treatment of COPD exacerbations","volume":"155","author":"Skorodin","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013506.pub2-BIB0040|cit40","first-page":"681","article-title":"Magnesium and obstructive lung diseases","volume":"126","author":"Sternfeld","year":"1994","journal-title":"Harefuah"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0041|cit41","unstructured":"Tagaya E Tamaoki J Kawatani K Nagai A The effect of isotonic nebulized magnesium sulfate on pulmonary function in moderate to severe COPD American Thoracic Society 100th international conference; 2004 May 21-26; Orlando 2004"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0042|cit42","unstructured":"Nebulized magnesium sulfate treatment in acute exacerbation of chronic obstructive pulmonary disease irct.ir\/trial\/17769"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.121.5.1441","article-title":"Mortality after hospitalisation for COPD","volume":"121","author":"Almagro","year":"2002","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.52609\/jmlph.v1i3.22","article-title":"Magnesium administration for COPD exacerbation: a systematic review and meta-analysis","volume":"1","author":"Alzaid","year":"2021","journal-title":"Journal of Medicine, Law and Public Health"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0045|cit45","unstructured":"American Lung Association Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality; 2013 www.lung.org\/getmedia\/4f74781e-481f-4f10-9255-8dfc9dc56974\/copd-trend-report.pdf.pdf"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0046|cit46","first-page":"245","article-title":"Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes","volume":"4","author":"Anzueto","year":"2009","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"116","key":"10.1002\/14651858.CD013506.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09059180.00002610","article-title":"Impact of exacerbations on COPD","volume":"19","author":"Anzueto","year":"2010","journal-title":"European Respiratory Review"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"179\u201391","DOI":"10.7326\/0003-4819-155-3-201108020-00008","article-title":"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society","volume":"155","author":"Qaseem","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0049|cit49","first-page":"423","article-title":"Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study","volume":"35","author":"Aziz","year":"2005","journal-title":"Annals of Clinical and Laboratory Science"},{"issue":"7","key":"10.1002\/14651858.CD013506.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.rmed.2008.02.010","article-title":"Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease","volume":"102","author":"Bhatt","year":"2008","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2458-9-8","article-title":"Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study","volume":"9","author":"Borrell","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0052|cit52","unstructured":"Scottish Intercollegiate Guidelines Network British Thoracic Society British guideline on the management of asthma: a national clinical guideline: revised edition published July 2019 www.sign.ac.uk\/sign-158-british-guideline-on-the-management-of-asthma.html"},{"issue":"12","key":"10.1002\/14651858.CD013506.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1553-2712.1996.tb03366.x","article-title":"Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients","volume":"3","author":"Cairns","year":"1996","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1183\/09031936.00109906","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"29","author":"Celli","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0056|cit56","unstructured":"Cochrane Airways Trials Register airways.cochrane.org\/trials-register"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD013506.pub2-BIB0057|cit57","first-page":"959","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)","volume":"154","author":"Dawson","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"175346661880566","DOI":"10.1177\/1753466618805662","article-title":"Asthma-COPD overlap: identification and optimal treatment","volume":"12","author":"Cosio","year":"2018","journal-title":"Therapeutic Advances in Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3945\/an.115.008524","article-title":"Magnesium","volume":"7","author":"Costello","year":"2016","journal-title":"Advances in Nutrition"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0060|cit60","first-page":"P4821","article-title":"Influence of COPD exacerbations on health related quality of life","volume":"40","author":"David","year":"2012","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1113\/jphysiol.1954.sp005114","article-title":"The nature of the neuromuscular block produced by magnesium","volume":"124","author":"Del-Castillo","year":"1954","journal-title":"Journal of Physiology"},{"issue":"10","key":"10.1002\/14651858.CD013506.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.200408-1054OC","article-title":"Exacerbations and time spent outdoors in chronic obstructive pulmonary disease","volume":"171","author":"Donaldson","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0011-5029(88)90013-2","article-title":"Magnesium metabolism in health and disease","volume":"34","author":"Elin","year":"1988","journal-title":"Disease-a-month"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0196-0644(96)70317-7","article-title":"Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease","volume":"27","author":"Emerman","year":"1996","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/83.2.302","article-title":"Magnesium: physiology and pharmacology","volume":"83","author":"Fawcett","year":"1999","journal-title":"British Journal of Anaesthesia"},{"issue":"7","key":"10.1002\/14651858.CD013506.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.2010.152876","article-title":"Lung function impairment, COPD hospitalisations and subsequent mortality","volume":"66","author":"Garcia-Aymerich","year":"2011","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma,1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","author":"Chronic Respiratory Disease Collaborators","year":"2017","journal-title":"Lancet Respiratory Medicine"},{"issue":"8","key":"10.1002\/14651858.CD013506.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.2008.108027","article-title":"The overlap syndrome of asthma and COPD: what are its features and how important is it?","volume":"64","author":"Gibson","year":"2009","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0070|cit70","unstructured":"Global Initiative for Asthma: Global strategy for asthma management and prevention (2018 update) ginasthma.org\/gina-ebooks"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0071|cit71","unstructured":"2021 Global Strategy for Prevention, Diagnosis and Management of COPD goldcopd.org\/2021-gold-reports\/"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0072|cit72","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Diagnosis of diseases of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS); 2015 goldcopd.org\/asthma-copd-asthma-copd-overlap-syndrome"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/089426801316970259","article-title":"Magnesium as a relaxing factor of airway smooth muscles","volume":"14","author":"Gourgoulianis","year":"2001","journal-title":"Journal of Aerosol Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0074|cit74","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"9","key":"10.1002\/14651858.CD013506.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/nu7095388","article-title":"Magnesium in prevention and therapy","volume":"7","author":"Grober","year":"2015","journal-title":"Nutrients"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalisation for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"329476","DOI":"10.1155\/2014\/329476","article-title":"Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study","volume":"2014","author":"Gumus","year":"2014","journal-title":"Pulmonary Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.00216013","article-title":"The clinical and genetic features of COPD-asthma overlap syndrome","volume":"44","author":"Hardin","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0079|cit79","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11882-017-0683-4","article-title":"Management of the asthma-COPD overlap syndrome (ACOS): a review of the evidence","volume":"17","author":"Hines","year":"2017","journal-title":"Current Allergy and Asthma Reports"},{"issue":"12","key":"10.1002\/14651858.CD013506.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0082|cit82","unstructured":"Jahangir A Zia Z Niazi MR Sahra S Jahangir A Sharif MA Efficacy of magnesium sulfate in the chronic obstructive pulmonary disease population: a systematic review and meta-analysis Advances in Respiratory Medicine 10.5603\/ARM.a2022.0012 35099052"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1183\/09031936.00194610","article-title":"Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study","volume":"39","author":"Jenkins","year":"2012","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"Journal of Asthma"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010909.pub2","article-title":"Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013506.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003898.pub6","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma","author":"Knightly","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"223","DOI":"10.22088\/cjim.12.2.223","article-title":"Chronic obstructive pulmonary disease: Is serum magnesium level risk factor for its acute exacerbation?","volume":"12","author":"Kshirsagar","year":"2021","journal-title":"Caspian Journal of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013506.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1513\/AnnalsATS.201508-554OC","article-title":"Characteristics and prevalence of asthma\/chronic obstructive pulmonary disease overlap in the United States","volume":"13","author":"Kumbhare","year":"2016","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2741\/1223","article-title":"Role of cellular magnesium in health and human disease","volume":"9","author":"Laires","year":"2004","journal-title":"Frontiers in Bioscience"},{"issue":"6","key":"10.1002\/14651858.CD013506.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S2213-2600(16)00098-9","article-title":"Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis","volume":"4","author":"Lange","year":"2016","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0091|cit91","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"j3772","DOI":"10.1136\/bmj.j3772","article-title":"Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets","volume":"358","author":"Leung","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1440-1843.2002.00417.x","article-title":"The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction","volume":"7","author":"Llewellin","year":"2002","journal-title":"Respirology"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"Lopez-Campos","year":"2016","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"2102006","DOI":"10.1183\/13993003.02006-2021","article-title":"DECODE-NET. ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations","volume":"59","author":"Mathioudakis","year":"2022","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD013506.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"issue":"7","key":"10.1002\/14651858.CD013506.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0098|cit98","first-page":"999","article-title":"Hospitalised exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort","volume":"147","author":"Mullerova","year":"2015","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Nannini LJ Hospitalization due to COPD exacerbation Chest 2012 142 6 1697 23208363","DOI":"10.1378\/chest.12-2204"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1151\u2013210","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0101|cit101","unstructured":"National Institute for Health and Care Excellence Chronic obstructive pulmonary disease in over 16s: diagnosis and management www.guidelines.co.uk\/respiratory\/nice-copd-guideline\/454912.article"},{"issue":"4","key":"10.1002\/14651858.CD013506.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/thx.2005.041830","article-title":"COPD exacerbations: pathophysiology","volume":"61","author":"O'Donnell","year":"2006","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1378\/chest.129.3.536","article-title":"Physical activity and hospitalisation for exacerbation of COPD","volume":"129","author":"Pitta","year":"2006","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0104|cit104","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0105|cit105","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1081\/copd-200050655","article-title":"Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale","volume":"2","author":"Ries","year":"2005","journal-title":"COPD"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-94-007-7500-8_3","article-title":"Magnesium in health and disease","volume":"13","author":"Romani","year":"2013","journal-title":"Metal Ions in Life Sciences"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001490","article-title":"Magnesium sulfate for treating exacerbations of acute asthma in the emergency department","author":"Rowe","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0109|cit109","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013506.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013506.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/1817-1737.128844","article-title":"Magnesium for acute exacerbation of chronic obstructive pulmonary disease: a systematic review of randomised trials","volume":"9","author":"Shivanthan","year":"2014","journal-title":"Annals of Thoracic Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013506.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2016.06.020","article-title":"Fifteen-year mortality of patients with asthma-COPD overlap syndrome","volume":"34","author":"Sorino","year":"2016","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2466-13-73","article-title":"Causes of death in asthma, COPD and non-respiratory hospitalised patients: a multicentric study","volume":"13","author":"Soto-Campos","year":"2013","journal-title":"BMC Pulmonary Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1164\/ajrccm.163.1.2005009","article-title":"Health status deterioration in patients with chronic obstructive pulmonary disease","volume":"163","author":"Spencer","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1002\/14651858.CD013506.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0196-0644(05)81513-6","article-title":"Effect of magnesium chloride on rabbit bronchial smooth muscle","volume":"19","author":"Spivey","year":"1990","journal-title":"Annals of Emergency Medicine"},{"issue":"9589","key":"10.1002\/14651858.CD013506.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD013506.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0119|cit119","unstructured":"WHO Global Health Estimates: The top 10 causes of death; 2020 www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0120|cit120","unstructured":"World Health Organization Chronic obstructive pulmonary disease (COPD) Fact sheets; 21 June 2021 www.who.int\/en\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)"},{"key":"10.1002\/14651858.CD013506.pub2-BIB0121|cit121","unstructured":"Yang IA Brown JL George J Jenkins S McDonald CF McDonald V The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2019. Version 2.59, August 2019 copdx.org.au\/copd-x-plan\/"},{"issue":"1","key":"10.1002\/14651858.CD013506.pub2-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013506","article-title":"Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease","author":"Ni","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:02:56Z","timestamp":1762128176000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013506.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":122,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013506.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}